review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Stephen T. Holgate | Q1547900 |
Hans Bisgaard | Q37615680 | ||
Leonardo M. Fabbri | Q42745775 | ||
P2093 | author name string | M Doherty | |
J Bousquet | |||
M D'Amato | |||
R Pauwels | |||
K F Chung | |||
J Y Reginster | |||
K Rabe | |||
F Cuss | |||
Group for the Respect of Ethics and Excellence in Science: Asthma section | |||
N J C Snell | |||
P433 | issue | 6 | |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 479-487 | |
P577 | publication date | 2004-06-01 | |
P1433 | published in | Respiratory Medicine | Q2659932 |
P1476 | title | Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma | |
P478 | volume | 98 |
Q64096294 | Clinical efficacy and safety of anticholinergic therapies in pediatric patients |
Q64096289 | Future perspectives of anticholinergics for the treatment of asthma in adults and children |
Q26783200 | Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews |
Q37711245 | The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). |
Search more.